Life sciences

The traditional companies active in the life sciences market are, after decades of relatively secure positions, facing serious challenges in the markets of today. In particular, innovative pharmaceutical companies see their positions change with the success of the generics. In order to keep their positions, the innovative will have to even more carefully manage their patent portfolios, taking into account the interest of the European competition authorities to guarantee a level playing field, while the generic companies will continue to play their role as the watchdogs of the freedom to compete and profit from the ideas of their competitors.

In this complex dance, where regulation is complex and often internationally diverse, companies need advice from a law firm like Brinkhof, that has all the knowledge and experience, whether patents, licensing or marketing authorization, whether national or European.